Wenling Zhejiang Measuring and Cutting Tools Trading Centre Balance Sheet Health
Financial Health criteria checks 4/6
Wenling Zhejiang Measuring and Cutting Tools Trading Centre has a total shareholder equity of CN¥790.0M and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.1B and CN¥289.1M respectively. Wenling Zhejiang Measuring and Cutting Tools Trading Centre's EBIT is CN¥47.9M making its interest coverage ratio -254.7. It has cash and short-term investments of CN¥44.0M.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | -254.7x |
Cash | CN¥44.02m |
Equity | CN¥790.05m |
Total liabilities | CN¥289.13m |
Total assets | CN¥1.08b |
Recent financial health updates
No updates
Recent updates
Wenling Zhejiang Measuring and Cutting Tools Trading Centre Company Limited's (HKG:1379) 29% Price Boost Is Out Of Tune With Earnings
Jun 19Wenling Zhejiang Measuring and Cutting Tools Trading Centre's (HKG:1379) Soft Earnings Don't Show The Whole Picture
Apr 28Calculating The Intrinsic Value Of Wenling Zhejiang Measuring and Cutting Tools Trading Centre Company Limited (HKG:1379)
Nov 03Wenling Zhejiang Measuring and Cutting Tools Trading Centre's (HKG:1379) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 26Calculating The Intrinsic Value Of Wenling Zhejiang Measuring and Cutting Tools Trading Centre Company Limited (HKG:1379)
Mar 30Financial Position Analysis
Short Term Liabilities: 1379's short term assets (CN¥47.3M) do not cover its short term liabilities (CN¥55.2M).
Long Term Liabilities: 1379's short term assets (CN¥47.3M) do not cover its long term liabilities (CN¥234.0M).
Debt to Equity History and Analysis
Debt Level: 1379 is debt free.
Reducing Debt: 1379 has no debt compared to 5 years ago when its debt to equity ratio was 4.6%.
Debt Coverage: 1379 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 1379 has no debt, therefore coverage of interest payments is not a concern.